The coding system is independent of the delivery mechanism and can be used within any delivery mechanism, including RFID technologies. The Blood Center of Wisconsin conducted a long study using ISBT 128 within RFID. The largest issue with Radio-Frequency Identification (RFID) is return on investment, so it has not been implemented in blood banks in the US. For cellular therapy products, it must be proven safe due to the minor amounts of radiation that could possibly do harm to the products. It is important to conduct tests to ensure that RFID is compatible with certain Human Cells, Tissues, and Cellular Tissue-Base Products (HTC/Ps).
USDM Life Sciences will help you assess, plan and execute the changes and enhancements necessary to meet UDI regulations. Our team of UDI experts will assess your products, the markets where they are sold and determine an implementation strategy for the changes that need to be made. USDM's assessment methodology is extensive and includes the labels and packaging, the management of identification changes to each product, the changes to PLM, ERP, EPCIS and packaging systems, changes to printing, vision inspection and warehouse/inventory management systems and interfaces to the GUDID.
No comments:
Post a Comment